RPL35 Activators are chemical compounds that have the ability to enhance the functional activity of Ribosomal Protein L35 (RPL35). RPL35 is a component of the large 60S subunit of the ribosome, the cellular machinery responsible for protein synthesis. These activators operate by directly or indirectly influencing the function of RPL35, either through its role in the ribosome or by modifying the cellular environment in which it operates. For instance, Rapamycin, an mTOR inhibitor, enhances the translation of specific mRNA transcripts such as RPL35, thereby enhancing its functional activity. Similarly, antibiotics like Azithromycin and Chloramphenicol bind to the 50S ribosomal subunit, influencing the function of RPL35 which is part of this ribosomal subunit. Protein synthesis inhibitors like Cycloheximide, Emetine, and Anisomycin change the translational landscape of the cell which can indirectly enhance the function of RPL35. Harringtonine and Homoharringtonine, plant alkaloids that inhibit protein synthesis by preventing translation elongation, can also directly influence the function of RPL35.
On the other hand, Actinomycin D, a DNA intercalator, and Mycophenolic acid, an inosine monophosphate dehydrogenase inhibitor, operate by affecting the cellular environment in which RPL35 functions. By inhibiting DNA transcription, ActinD changes the pool of mRNAs available for translation, indirectly enhancing RPL35 function. Similarly, mycophenolic acid disrupts guanosine nucleotide synthesis, indirectly influencing RPL35 function by altering the pool of nucleotides available for protein translation. Other RPL35 activators like Puromycin, an aminonucleoside antibiotic, and Tunicamycin, a nucleoside antibiotic that inhibits N-linked glycosylation, affect RPL35 function by acting on the ribosome or altering protein synthesis and maturation. By causing premature chain termination during translation, Puromycin influences RPL35 function. Tunicamycin, on the other hand, alters protein synthesis and maturation, influencing RPL35 function.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. Ribosomal Protein L35 (RPL35) is part of the ribosome machinery, which is directly regulated by mTOR. By inhibiting mTOR, rapamycin decreases protein synthesis globally, but paradoxically enhances the translation of specific mRNA transcripts like RPL35, enhancing its functional activity. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide is a potent inhibitor of protein synthesis in eukaryotes by affecting the elongation phase in the ribosome. By targeting the ribosome, cycloheximide can influence the activity of RPL35, as it is a component of the ribosome. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin is an aminonucleoside antibiotic, found in the Streptomyces alboniger bacterium, that causes premature chain termination during translation taking place in the ribosome. Acting on the ribosome, it can influence RPL35 function. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D is a DNA intercalator that inhibits DNA transcription. By inhibiting transcription, it influences ribosomal activity and indirectly enhances RPL35 function by modifying the pool of mRNAs available for translation. | ||||||
Azithromycin | 83905-01-5 | sc-254949 sc-254949A sc-254949B sc-254949C sc-254949D | 25 mg 50 mg 500 mg 1 g 5 g | $52.00 $103.00 $260.00 $364.00 $728.00 | 17 | |
Azithromycin is an antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit,which influences the function of RPL35 as it is part of the large ribosomal subunit. | ||||||
Chloramphenicol | 56-75-7 | sc-3594 | 25 g | $90.00 | 10 | |
Chloramphenicol is an antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, influencing the function of RPL35. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $440.00 $900.00 $1400.00 $2502.00 | ||
Emetine is a protein synthesis inhibitor. By inhibiting protein synthesis, it could indirectly enhance the function of RPL35 by modifying the translational landscape of the cell. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is an antibiotic that inhibits protein synthesis by binding to the 60S ribosomal subunit, directly influencing the function of RPL35. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
Harringtonine is a cephalotaxine alkaloid that inhibits protein synthesis by preventing the elongation phase of translation, thereby influencing RPL35 function. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin is a nucleoside antibiotic that inhibits N-linked glycosylation, an important post-translational modification. By altering protein synthesis and maturation, it can influence RPL35 function. | ||||||